Identification of selective hepatitis delta virus ribozyme inhibitors by high-throughput screening of small molecule libraries.

Tseligka, Eirini D; Conzelmann, Stéphanie; Cambet, Yves; Schaer, Tifany; Negro, Francesco; Clément, Sophie

Tseligka, Eirini D; Conzelmann, Stéphanie; Cambet, Yves; Schaer, Tifany; Negro, Francesco; Clément, Sophie.

Afiliación

Tseligka ED; Department of Pathology and Immunology, University of Geneva, Switzerland.
Conzelmann S; Department of Pathology and Immunology, University of Geneva, Switzerland.
Cambet Y; Department of Pathology and Immunology, University of Geneva, Switzerland.
Schaer T; READS Unit, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
Negro F; Department of Pathology and Immunology, University of Geneva, Switzerland.
Clément S; Clinical Pathology, Geneva University Hospital, Geneva, Switzerland.

JHEP Rep ; 5(3): 100652, 2023 Mar.

Article en En | MEDLINE | ID: mdl-36704052

Palabras clave

8-azaguanine; CC50, half maximal cytotoxic concentration; HBV, hepatitis B virus; HBsAg, HBV surface antigen; HDAC, histone deacetylase; HDV Ribozyme; HDV, hepatitis delta virus; HTS, high-throughput screening; Hepatitis Delta Virus; High-Throughput Screening; IC50, half maximal inhibitory concentration; antiviral drug

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Prognostic_studies / Screening_studies Idioma: En Revista: JHEP Rep Año: 2023 Tipo del documento: Article País de afiliación: Suiza

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google